GRAF FINCKENSTEIN FRIEDRICH 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Iovance (IOVA) CMO Graf Finckenstein Receives RSUs, Withholds Shares
What Happened
Graf Finckenstein, Chief Medical Officer of Iovance Biotherapeutics (IOVA), had 31,246 restricted stock units (RSUs) vest on March 5, 2026. The RSUs converted into common stock at a $0.00 exercise price (typical for RSU vesting). To satisfy tax withholding, 16,520 shares were withheld by the company at $4.58 per share (total ~$75,662), leaving 14,726 shares issued to the insider.
Key Details
- Transaction date: March 5, 2026; Form filed March 6, 2026.
- Vesting/Conversion: 31,246 RSUs -> 31,246 common shares (code M, $0.00).
- Tax withholding: 16,520 shares withheld (code F) at $4.58/share = $75,662 (this is not an open‑market sale).
- Net shares delivered to insider after withholding: 14,726 shares.
- Relevant footnotes: RSUs vested on the transaction date; withheld shares satisfy mandatory tax withholding (not a market sale); each RSU equals one share; remaining RSUs vest quarterly and reflect the remainder of the March 5, 2025 grant.
- Filing timeliness: filed one day after the transaction date (appears timely).
Context
This was a routine vesting of RSUs (an award), not an open‑market purchase or sell order. The company withheld shares to cover taxes (a net settlement), which is common and does not necessarily indicate the insider sold shares on the market. Remaining RSUs from the referenced grant will continue to vest in equal quarterly installments.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-03-05+31,246→ 148,477 total - Tax Payment
Common Stock
[F2][F3]2026-03-05$4.58/sh−16,520$75,662→ 131,957 total - Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]2026-03-05−31,246→ 62,504 total→ Common stock (31,246 underlying)
Footnotes (6)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.